ICON PLC (ICLR) Fundamental Analysis & Valuation
NASDAQ:ICLR • IE0005711209
108.7 USD
+0.43 (+0.4%)
At close: Mar 3, 2026
108 USD
-0.7 (-0.64%)
Pre-Market: 3/4/2026, 5:41:42 AM
This ICLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Taking everything into account, ICLR scores 5 out of 10 in our fundamental rating. ICLR was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ICLR get a neutral evaluation. Nothing too spectacular is happening here. ICLR is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make ICLR suitable for value investing!
1. ICLR Profitability Analysis
1.1 Basic Checks
- In the past year ICLR was profitable.
- In the past year ICLR had a positive cash flow from operations.
- In the past 5 years ICLR has always been profitable.
- Each year in the past 5 years ICLR had a positive operating cash flow.
1.2 Ratios
- With a decent Return On Assets value of 3.63%, ICLR is doing good in the industry, outperforming 77.19% of the companies in the same industry.
- The Return On Equity of ICLR (6.42%) is better than 77.19% of its industry peers.
- With a decent Return On Invested Capital value of 6.74%, ICLR is doing good in the industry, outperforming 78.95% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ICLR is significantly below the industry average of 11.60%.
- The last Return On Invested Capital (6.74%) for ICLR is above the 3 year average (5.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
- ICLR's Profit Margin of 7.40% is fine compared to the rest of the industry. ICLR outperforms 77.19% of its industry peers.
- In the last couple of years the Profit Margin of ICLR has declined.
- ICLR has a better Operating Margin (13.99%) than 75.44% of its industry peers.
- ICLR's Operating Margin has been stable in the last couple of years.
- ICLR has a worse Gross Margin (28.15%) than 77.19% of its industry peers.
- In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. ICLR Health Analysis
2.1 Basic Checks
- ICLR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, ICLR has less shares outstanding
- Compared to 5 years ago, ICLR has more shares outstanding
- ICLR has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 1.62, we must say that ICLR is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.62, ICLR is in line with its industry, outperforming 54.39% of the companies in the same industry.
- ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
- ICLR's Debt to FCF ratio of 3.53 is amongst the best of the industry. ICLR outperforms 80.70% of its industry peers.
- ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.31, ICLR perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 1.62 |
ROIC/WACC0.76
WACC8.83%
2.3 Liquidity
- A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.06, ICLR is doing worse than 82.46% of the companies in the same industry.
- ICLR has a Quick Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
- ICLR's Quick ratio of 1.06 is on the low side compared to the rest of the industry. ICLR is outperformed by 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. ICLR Growth Analysis
3.1 Past
- The earnings per share for ICLR have decreased by -5.99% in the last year.
- Measured over the past years, ICLR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.23% on average per year.
- ICLR shows a decrease in Revenue. In the last year, the revenue decreased by -2.46%.
- ICLR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.17% yearly.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
- Based on estimates for the next years, ICLR will show a small growth in Earnings Per Share. The EPS will grow by 2.14% on average per year.
- ICLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.48% yearly.
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ICLR Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 8.24 indicates a reasonable valuation of ICLR.
- Compared to the rest of the industry, the Price/Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.25% of the companies listed in the same industry.
- ICLR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.83.
- Based on the Price/Forward Earnings ratio of 8.46, the valuation of ICLR can be described as reasonable.
- Based on the Price/Forward Earnings ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ICLR to the average of the S&P500 Index (24.95), we can say ICLR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.46 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.61 | ||
| EV/EBITDA | 7.38 |
4.3 Compensation for Growth
- The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
5. ICLR Dividend Analysis
5.1 Amount
- No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ICLR Fundamentals: All Metrics, Ratios and Statistics
108.7
+0.43 (+0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)04-30 2026-04-30/amc
Inst Owners105.53%
Inst Owner Change4.32%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap8.30B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target159.5 (46.73%)
Short Float %2.65%
Short Ratio1.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-23.67%
PT rev (3m)-23.97%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)-2.29%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)-0.49%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.46 | ||
| P/S | 1.02 | ||
| P/FCF | 8.61 | ||
| P/OCF | 7.28 | ||
| P/B | 0.89 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.38 |
EPS(TTM)13.19
EY12.13%
EPS(NY)12.85
Fwd EY11.82%
FCF(TTM)12.63
FCFY11.62%
OCF(TTM)14.93
OCFY13.74%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.54
Graham Number190.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.62 |
F-Score6
WACC8.83%
ROIC/WACC0.76
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.44%
EBIT Next 3Y0.52%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status for ICLR stock?
ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.
How profitable is ICON PLC (ICLR) stock?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
What is the valuation of ICON PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 8.24 and the Price/Book (PB) ratio is 0.89.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 5 / 10.